Lobsters hold the secret of a long, cancer-free life in their genes
The American lobster — easily recognizable by its two hefty claws — can reach the impressive age of 100 years. The remarkable longevity is accompanied by very few signs of aging; it continuously grows and reproduces throughout its life and does not suffer from age-related diseases such as cancer. This exceptional resilience has garnered interest from researchers that are curious to decipher the reasons behind the lobster’s longevity and good health.

Could the genome of the American lobster provide clues about their healthy aging? Researchers at the Gloucester Marine Genomics Institute have recently published the first draft of the American lobster genome, which revealed surprising, first insights into the animal’s unique resilience mechanisms. Their work was published in the journal Science Advances.
The researchers found genes encoding for a novel class of proteins that combine both neuronal and immune-related functions. By coupling the neural and immune system, the lobster could fight off pathogens more efficiently.
The researchers also surveyed the lobster genome for genes involved in safeguarding the genome. These safeguards prevent genomic alterations and mutations, which is crucial for longevity and warding off cancer. The researchers found that the American lobster has an extended repertoire of genes encoding for proteins that silence certain regions of the genome. These regions need to be silenced to prevent potentially disease-causing mutations such as chromosomal rearrangements. By ensuring that these regions remain silenced, the American lobster safeguards its genome throughout its long life.
With the newly deciphered lobster genome as a starting point, future research will provide further insight into the healthy aging strategies of the American lobster. More than a mere delicacy, the humble lobster could teach us a lot about healthy aging.
This story originally appeared on Massive Science, an editorial partner site that publishes science stories by scientists. Subscribe to their newsletter to get even more science sent straight to you.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.